您的位置: 首页 > 农业专利 > 详情页

CONJUGUÉS CIBLANT HSP90 ET FORMULATIONS DE CES DERNIERS
专利权人:
Tarveda Therapeutics; Inc.
发明人:
申请号:
EP18887279.0
公开号:
EP3723811A1
申请日:
2018.12.14
申请国别(地区):
EP
年份:
2020
代理人:
摘要:
Conjugates of an active agent attached to a targeting moiety, such as an HSP90 binding moiety, via a linker, and particles comprising such conjugates have been designed. Such conjugates and particles can provide improved temporospatial delivery of the active agent, improved biodistribution and penetration in tumor, and/or decreased toxicity. Methods of making the conjugates, the particles, and the formulations thereof are provided. Methods of administering the formulations to a subject in need thereof are provided, for example, to treat or prevent cancer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充